The term viral refers to an infection driven by a virus and examples include COVID-19, AIDS, measles, hepatitis, and smallpox. Viruses contain DNA or RNA and must infect host cells in order to replicate and they can damage the host during this process. Antiviral medications or vaccines can treat viral infections.
-
Date: August 18, 2021 Time: 8:00am (PDT), 11:00am (EDT) Discover the tools to phenotype your NK cells and to perform functional analyses such as cellular cytotoxicity assays. From NK cell is...
Date: July 27, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Dr Gish (Insert credentials and role with Hep B Foundation) will cover current USPSTF recommendations (risk based) and HBFoundation for...
Date: July 27, 2021 Time: 8:00am (PDT), 11:00am (EDT) The Origin of Biopharmaceutics (Biopharma) derive from The Division of Clinical Research in the U.S. Bureau of Medicine. However, author...
Genome editing technologies have enabled the precise manipulation of DNA sequences at targeted sites to achieve therapeutic effects. Engineered endonucleases like CRISPR-Cas9 institute site-...
Learning Objectives: 1. Delivery vehicles for the Cas9 RNP 2. Gene editing after a direct tissue injection 3. New linkers for conjugating proteins to polymers...
Gene editing technologies such as CRISPR/Cas9 have greater flexibility and high efficiency. CRISPR technology enables targeted insertion of transgenes at the desired locus and has the abilit...
Human T cells are critical effectors of immune protection from infections, autoimmune pathology, and cancer immunotherapy. We use CRISPR-mediated gene editing in primary human T cells to sys...
Date: July 15, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Sigma Metrics plays a critical role in laboratory medicine. Abbott is committed to helping your laboratory achieve excellence in clinica...
Date: July 8, 2021 Time: 8:00am (PDT) Cell-based chimeric antigen receptor (CAR) T cell therapies have rapidly advanced in recent years, with a variety of targets in clinical research and se...
Date: June 29, 2021 Time: 08:00am PDT As the SARS-CoV-2 virus that causes COVID-19 keeps mutating, there is a growing need to sequence the viral genome from many COVID-19-positive samples to...
Date: June 23, 2021 Time: 9:00am PDT Adeno-associated virus (AAV) is rapidly becoming the go-to biological delivery method for the latest gene therapy breakthroughs. AAV has an efficacy and...
Date: June 16, 2021 Time: 11:00am (PDT), 2:00pm (EDT) Large-scale wastewater surveillance can be used to help communities monitor infection dynamics for SARS-CoV-2. Wide-spread implementatio...
Recombinant adeno-associated viral (rAAV) vectors have emerged as the leading gene delivery platform for gene therapy. Leveraging LC and LC-MS methods for the characterization of AAV product...